Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03154827
Title A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioLineRx, Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SVK | POL | ISR | ESP | CZE

Facility Status City State Zip Country Details
The University of Texas - Md Anderson Cancer Center - Leukemia Center Houston Texas 77030 United States Details
Medical College of Wisconsin/Froedtert Hospital Milwaukee Wisconsin 53226 United States Details
Fakultni Nemocnice Brno / University Hospital Brno Interni Hematologicka A Onkologicka Klinika / Internal Hematology and Oncology Clinic Brno Czechia Details
Fakultni Nemocnice Ostrava (Fno) / University Hospital Ostrava Klinika Hematoonkologie / Hematooncology Clinic Ostrava Czechia Details
Fakultni Nemocnice Kralovske Vinohrady Fnkv / University Hospital Kralovske Vinohrady Interní Hematologická Klinika Fnkv / Internal Hematology Clinic Praha Czechia Details
Rambam Medical Center Haifa Israel Details
Shaarei Tzedek Medical Center Jerusalem Israel Details
Wojewódzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im. M. Kopernika W Lodzi Łódź Poland Details
Národný Onkologický Ústav / National Cancer Institute, Oddelenie Onkohematológie Ii / Department of Oncohematology Ii Bratislava Slovakia Details
Hospital San Pedro de Alcántara de Cáceres Caceres Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Hospital Universitario La Fe de Valencia Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field